EGFR / TRP channels
Name: Epidermal growth factor receptor
(EGFR)
Official Symbol: EGFR
provided by HGNC
Function:
Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo-and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin.Isoform 2 may act as an antagonist of EGF action.
Source: Reorganizing the protein space at the Universal Protein Resource (UniProt)
Nucleic Acids Res. 40: D71-D75 (2012).
Species | External DB | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Entrez Gene | UniprotKB | DIP | IntAct | MINT | BioGRID | STRING | IUPHAR-DB | KEGG | OMIM | |
Human
|
1956 | P00533 | DIP-405N DIP-5764N |
P00533 | MINT-206389 | 108276 | P00533 | hsa:1956 | 131550 | |
Mouse
|
13649 | Q01279 | DIP-5763N | MINT-143143 | 199402 | Q01279 | mmu:13649 | |||
Rat
|
24329 | Q9QX70 | DIP-2658N | Q9QX70 | MINT-1509350 | 246506 | Q9QX70 | rno:24329 |
Biological Process:
- GO:0043006 : activation of phospholipase A2 activity by calcium-mediated signaling
- GO:0007202 : activation of phospholipase C activity
- GO:0007411 : axon guidance
- GO:0008283 : cell proliferation
- GO:0016337 : cell-cell adhesion
- GO:0021795 : cerebral cortex cell migration
- GO:0048546 : digestive tract morphogenesis
- GO:0001892 : embryonic placenta development
- GO:0001942 : hair follicle development
- GO:0060571 : morphogenesis of an epithelial fold
- GO:0043066 : negative regulation of apoptotic process
- GO:0042059 : negative regulation of epidermal growth factor receptor signaling pathway
- GO:0042177 : negative regulation of protein catabolic process
- GO:0001503 : ossification
- GO:0035413 : positive regulation of catenin import into nucleus
- GO:0030335 : positive regulation of cell migration
- GO:0031659 : positive regulation of cyclin-dependent protein kinase activity involved in G1/S
- GO:0045739 : positive regulation of DNA repair
- GO:0045740 : positive regulation of DNA replication
- GO:0050679 : positive regulation of epithelial cell proliferation
- GO:0048146 : positive regulation of fibroblast proliferation
- GO:0043406 : positive regulation of MAP kinase activity
- GO:0045429 : positive regulation of nitric oxide biosynthetic process
- GO:0051897 : positive regulation of protein kinase B signaling cascade
- GO:0046777 : protein autophosphorylation
- GO:0051205 : protein insertion into membrane
- GO:0050999 : regulation of nitric-oxide synthase activity
- GO:0050730 : regulation of peptidyl-tyrosine phosphorylation
- GO:0006950 : response to stress
- GO:0070141 : response to UV-A
- GO:0007435 : salivary gland morphogenesis
Source: The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet.. May 2000;25(1):25-9.
World Wide Web URL: http://www.geneontology.org/
World Wide Web URL: http://www.geneontology.org/
Disease:
- OMIM:131550 : Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in (OMIM:211980 )
- OMIM:131550 : Adenocarcinoma of lung, response to tyrosine kinase inhibitor in (OMIM:211980 )
- OMIM:131550 : Nonsmall cell lung cancer, susceptibility to (OMIM:211980 )
Source: Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine,
Johns Hopkins University (Baltimore, MD), May, 2012.
World Wide Web URL: http://omim.org/
World Wide Web URL: http://omim.org/
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Screening | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Experimental screening | Non-experimental screening | Reference | ||||||||
TRP channel construct | Interactor source | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Organ/tissue | Sample type | |||
TRPP1 | EGFR | Inference | Prediction | 16135816 | ||||||
TRPV1 | EGFR | Inference | Prediction | 19155296 | ||||||
TRPV3 | EGFR | Inference | Prediction | 20403327 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Validation: In vitro validation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Assay with recombinant proteins | Reference | |||||||||
TRP channel construct | Interactor construct | |||||||||
TRP channel | Interactor | Method | Species | Region | Expression system | Species | Region | Expression system | ||
TRPV1 | EGFR | Fusion protein-pull down assay | Not specified | 680-838 | HEK293 lysates | Not used | A431 Human epithelial carcinoma cell line | 19155296 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Validation: In vivo validation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Assay with endogenous proteins | Assay with overexpressed proteins | Reference | ||||||||
Cell or tissue | Cell or tissue | TRP channel construct | Interactor construct | |||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPP1 | EGFR | Co-immunofluorescence staining | LLC-PK1 | 16135816 | ||||||
TRPP1 | EGFR | Co-immunoprecipitation | HEK293T | Human | Full-length | Human | Full-length | 16135816 | ||
TRPV1 | EGFR | Co-immunoprecipitation | HEK293 | Not specified | Full-length | Not used | 19155296 | |||
TRPV1 | EGFR | Co-immunoprecipitation | HaCaT | 19155296 | ||||||
TRPV3 | EGFR | Co-immunoprecipitation | TRPV3-YFP transgenic mouse skin tissue | 20403327 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Characterization | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Binding region mapping | Stoichiometry | Affinity (Kd) | Reference | |||||||
TRP channel | Interactor | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPP1 | EGFR | Co-immunoprecipitation | Human | 1-871 | Human | Not determined | 16135816 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Functional consequence | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
TRP channel | Interactor | Method | Post-translational modification | Subcellular trafficking | Activity | Reference | ||||||
TRPV3 | EGFR | Calcium measurement | Activation | 20403327 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)